Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 221.4 SEK 4.04% Market Closed
Market Cap: 30B SEK
Have any thoughts about
Vitrolife AB?
Write Note

Vitrolife AB
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vitrolife AB
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Vitrolife AB
STO:VITR
Total Receivables
kr708m
CAGR 3-Years
44%
CAGR 5-Years
23%
CAGR 10-Years
25%
Biogaia AB
STO:BIOG B
Total Receivables
kr133.9m
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Receivables
kr224.6m
CAGR 3-Years
70%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Probi AB
STO:PROB
Total Receivables
kr114.8m
CAGR 3-Years
16%
CAGR 5-Years
-2%
CAGR 10-Years
17%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Receivables
kr8.1B
CAGR 3-Years
27%
CAGR 5-Years
24%
CAGR 10-Years
29%
BioArctic AB
STO:BIOA B
Total Receivables
kr7.1m
CAGR 3-Years
8%
CAGR 5-Years
13%
CAGR 10-Years
N/A
No Stocks Found

Vitrolife AB
Glance View

Market Cap
30B SEK
Industry
Biotechnology

Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 427 full-time employees. The company went IPO on 2001-06-26. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. The company also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The firm is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

VITR Intrinsic Value
139.61 SEK
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Vitrolife AB's Total Receivables?
Total Receivables
708m SEK

Based on the financial report for Sep 30, 2024, Vitrolife AB's Total Receivables amounts to 708m SEK.

What is Vitrolife AB's Total Receivables growth rate?
Total Receivables CAGR 10Y
25%

Over the last year, the Total Receivables growth was 32%. The average annual Total Receivables growth rates for Vitrolife AB have been 44% over the past three years , 23% over the past five years , and 25% over the past ten years .

Back to Top